Zobrazeno 1 - 10
of 25
pro vyhledávání: '"L H Elliott"'
Publikováno v:
The Journal of Immunology. 159:4415-4425
It has been well established that patients with malignant glioblastomas exhibit T cell anergy. In this report, we further investigate the nature of this T cell anergy. The results demonstrate that tumor size but not location correlates with decreased
Autor:
J. Bishop, M. Brewster, J. M. Budd, David Bradshaw, F. Rose, Brown Paul Anthony, William Henry Johnson, K. M. K. Bottomley, Michael J. Broadhurst, K. Wilson, J. S. Nixon, B.M. Sutton, A. Greenham, L H Elliott, E. J. Lewis
Publikováno v:
British Journal of Pharmacology. 121:540-546
1. Ro 32-3555 (3(R)-(cyclopentylmethyl)-2(R)-[(3,4,4-trimethyl-2,5-dioxo-1- imidazolidinyl)methyl]-4-oxo-4-piperidinobutyrohydroxamic acid) is a potent, competitive inhibitor of human collagenases 1, 2 and 3 (Ki values of 3.0, 4.4 and 3.4 nM, respect
Autor:
Hans Werner Lahm, Pat Eyers, Brown Paul Anthony, Michael J. Broadhurst, L H Elliott, John M. Budd, Trevor J. Hallam, Urs Röthlisberger, David Bradshaw, Geoffrey Lawton, Amanda Whittle, J. S. Nixon, Maisie James, Hill Christopher Huw, Janet E. Merritt, Neera Borkakoti, William Henry Johnson, Balraj Krishnan Handa, K. M. K. Bottomley
Publikováno v:
Biochemical Journal. 323:483-488
N-terminal analysis of aggrecan fragments lost from bovine nasal cartilage cultured in the presence of recombinant human interleukin 1alpha revealed a predominant ARGSVIL sequence with an additional ADLEX sequence. Production of the ARGSVIL-containin
Autor:
H. Kumar, J. Bishop, Hill Christopher Huw, D. Westmacott, Geoffrey Lawton, Peter D. Davis, J. S. Nixon, David Bradshaw, Sandra E. Wilkinson, L H Elliott, E. J. Lewis, MJ Mulqueen, J. Wadsworth
Publikováno v:
Biochemical Society Transactions. 20:419-425
Autor:
Anthony D. Sedgwick, Peter D. Davis, L H Elliott, Geoffrey Lawton, J. S. Nixon, Sandra E. Wilkinson, Hill Christopher Huw
Publikováno v:
Biochemical and Biophysical Research Communications. 171:148-154
The inhibition of phosphorylase kinase by a number of protein kinase inhibitors was examined. Both K252a and staurosporine are potent inhibitors of phosphorylase kinase with IC50 values of 1.7 nM and 0.5 nM respectively. K252a shows a 300-fold select
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 159(9)
It has been well established that patients with malignant glioblastomas exhibit T cell anergy. In this report, we further investigate the nature of this T cell anergy. The results demonstrate that tumor size but not location correlates with decreased
Autor:
A M, Birchall, J, Bishop, D, Bradshaw, A, Cline, J, Coffey, L H, Elliott, V M, Gibson, A, Greenham, T J, Hallam, W, Harris
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 268(2)
Several lines of circumstantial evidence support the assumption that protein kinase C (PKC) activation together with elevated levels of cytosolic Ca++ are necessary for T-cell activation and proliferation in response to a physiological stimulus, i.e.
Autor:
Elizabeth Keech, Harris William, M. K. Hari Kumar, John S. Nixon, L H Elliott, Steven A. Hurst, Sandra E. Wilkinson, Geoffrey Lawton, Hill Christopher Huw, Davis Peter David
Publikováno v:
Journal of medicinal chemistry. 35(6)
A hypothetical mode of inhibition of protein kinase C (PKC) by the natural product staurosporine has been used as a basis for the design of substituted bisindolylmaleimides with improved potency over the parent compound. Structure-activity relationsh
Autor:
J S, Nixon, J, Bishop, D, Bradshaw, P D, Davis, C H, Hill, L H, Elliott, H, Kumar, G, Lawton, E J, Lewis, M, Mulqueen
Publikováno v:
Drugs under experimental and clinical research. 17(8)
Clarification of the precise role of protein kinase C (PKC) in cellular functional responses has been hampered by a lack of potent, selective inhibitors. The structural lead provided by staurosporine, a potent but non-selective protein kinase (PK) in
Publikováno v:
Journal of Investigative Medicine. 52:S286.2-S286